Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.52 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3845206 | 0.94 | CPB2 (0.50) | CA2CA1CPB2MAPK1SLC1A2 | |
| SCHEMBL277442 | 0.92 | CPB2 (0.53) | CA2CA1CPB2MAPK1SLC1A2 | |
| SCHEMBL319980 | 0.92 | CPB2 (0.53) | CA2CA1CPB2MAPK1SLC1A2 | |
| Ammonia Solution, Strong SCHEMBL5121318 | 0.90 | CPB2 (0.51) | CA2CA1CPB2MAPK1SLC1A2 | |
| Methyl Alcohol SCHEMBL7668985 | 0.90 | CPB2 (0.51) | CA2CA1CPB2MAPK1SLC1A2 | |
| SCHEMBL5491480 | 0.89 | CA2 (0.57) | CA2CA1CPB2MAPK1ALDH1A1 | |
| SCHEMBL5000143 | 0.88 | CPB2 (0.47) | CA2CA1CPB2ALDH1A1TDP1 | |
| Acetic Acid SCHEMBL3260364 | 0.87 | CPB2 (0.49) | CA2CA1CPB2SLC1A2SLC1A1 | |
| SCHEMBL21052329 | 0.87 | CA2 (0.55) | CA2CA1CPB2MAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL27486062 | 0.87 | CA2 (0.55) | CA2CA1CPB2MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110662746-B | Compounds as orally administered prodrugs of beta-lactamase inhibitors, pharmaceutical compositions thereof and use for treating bacterial infections | 阿里萨制药有限公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-111448182-A | Aztreonam derivative and application thereof | 阿里萨制药有限公司 | 2020-07-24 | — | — | CN | disclosed |
| CN-110662746-A | Prodrugs of 3- ((((((2S,5R) -2-carbamoyl-7-oxo-1, 6-diazabicyclo [3.2.1] oct-6-yl) oxy) sulfonyl) oxy) -2, 2-dimethylpropionate derivatives and related compounds for oral administration as beta-lactamase inhibitors for treating bacterial infections | 阿里萨制药有限公司 | 2020-01-07 | — | — | CN | disclosed |
| EP-1717276-B1 | HETEROPOLYCYCLIC COMPOUND AND DYE | UNIV KOCHI (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-7666659-B2 | Process for producing optically active 3-hydroxypropionic ester derivative | KANEKA CORPORATION (JP) | 2010-02-23 | — | — | US | disclosed |
| US-20100016627-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-HYDROXYPROPIONIC ESTER DERIVATIVE | KANEKA CORPORATION (JP) | 2010-01-21 | — | — | US | disclosed |
| US-7408072-B2 | Heteropolycyclic compound and dye | KOCHI UNIVERSITY (JP) | 2008-08-05 | — | — | US | disclosed |
| US-20070185338-A1 | Benzo[c]carbazoles, benzo[b]naphthofurans, benzo[kl]xanthenes, and benzo[kl]acridines oxo- and tertiary amine-substituted; high luminescence intensities; heat resistance, light resistance, solubility, dispersibility in resist materials; emit light in solution and in solid state | KOCHI UNIVERSITY (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1717276-A1 | HETEROPOLYCYCLIC COMPOUND AND DYE | Kochi University (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-20060166342-A1 | Process for producing optically active 3-hydroxypropionic ester derivative | KANEKA CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1568679-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-HYDROXYPROPIONIC ESTER DERIVATIVE | KANEKA CORPORATION (JP) | 2005-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185338-A1 | Benzo[c]carbazoles, benzo[b]naphthofurans, benzo[kl]xanthenes, and benzo[kl]acridines oxo- and tertiary amine-substituted; high luminescence intensities; heat resistance, light resistance, solubility, dispersibility in resist materials; emit light in solution and in solid state | ABCG2, IK, XDH | CA2 2658/4885CA1 4085/4885CPB2 4595/4885 |
| US-20100016627-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-HYDROXYPROPIONIC ESTER DERIVATIVE | HPD, GRHPR, PAH | CA2 462/4885CA1 1796/4885CPB2 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.